{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:58:41Z","timestamp":1785243521394,"version":"3.55.0"},"reference-count":247,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunotherapy has redefined oncology, yet its efficacy remains constrained by low response rates, primary or acquired resistance, immune-related toxicities, and escalating costs. Bacteria-mediated cancer immunotherapy (BCIT), which exploits the intratumoral microbiota as a programmable immunotherapeutic platform, has therefore emerged as a promising strategy. Although anecdotal links between infection and tumor regression were documented over four millennia ago, the molecular underpinnings of BCIT have only recently become accessible through synthetic biology, single-cell sequencing, and gnotobiotic modeling. Here we synthesize current knowledge on how intratumoral bacteria either enhance or suppress malignancy via genotoxicity, epigenetic reprogramming, metabolic competition, and modulation of the tumor-immune interface. We dissect cutting-edge engineering approaches\u2014quorum-sensing circuits, thermo-inducible switches, molecular mimicry, and biohybrid microrobots, that convert commensal or attenuated pathogenic strains into precision delivery vehicles for cytokines, checkpoint inhibitors, and neoantigens. Finally, we critically evaluate translational bottlenecks (safety, pharmacokinetics, regulatory science, inter-patient heterogeneity) and propose an AI-guided, microbiome-integrated framework to accelerate clinical translation. This Review provides a conceptual framework for harnessing living therapeutics to convert immunologically \u201ccold\u201d tumors into \u201chot\u201d, therapy-sensitive lesions, and discusses key directions for future microbiome-driven oncology trials.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1878878","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:59:46Z","timestamp":1785239986000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular mechanisms of bacteria-mediated cancer immunotherapy: from intratumoral microbiota to engineered therapeutics"],"prefix":"10.3389","volume":"17","author":[{"given":"Jinhu","family":"Guo","sequence":"first","affiliation":[{"name":"Yan\u2019an Medical College, Yan\u2019an University","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Li","sequence":"additional","affiliation":[{"name":"Yan\u2019an Medical College, Yan\u2019an University","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[{"name":"Yan\u2019an Medical College, Yan\u2019an University","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobo","family":"Wang","sequence":"additional","affiliation":[{"name":"Yan\u2019an Medical College, Yan\u2019an University","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment: Immunomodulation, cars and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma","volume":"24","author":"Gide","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40425-018-0382-2","article-title":"The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (nsclc)","volume":"6","author":"Brahmer","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00587-0","article-title":"Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (poplar): A multicentre, open-label, phase 2 randomised controlled trial","volume":"387","author":"Fehrenbacher","year":"2016","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.015","article-title":"The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy","volume":"33","author":"Gopalakrishnan","year":"2018","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","article-title":"Targeting the gut and tumor microbiota in cancer","volume":"28","author":"Park","year":"2022","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192282","article-title":"Intratumoral accumulation of gut microbiota facilitates cd47-based immunotherapy via sting signaling","volume":"217","author":"Shi","year":"2020","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2095-1","article-title":"Microbiome analyses of blood and tissues suggest cancer diagnostic approach","volume":"579","author":"Poore","year":"2020","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","article-title":"Breast cancer colonization by fusobacterium nucleatum accelerates tumor growth and metastatic progression","volume":"11","author":"Parhi","year":"2020","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.09.009","article-title":"The intratumoral microbiome: Characterization methods and functional impact","volume":"522","author":"Heymann","year":"2021","journal-title":"Cancer Lett"},{"key":"B17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","article-title":"Exploring the emerging role of the microbiome in cancer immunotherapy","volume":"7","author":"Fessler","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100884","article-title":"Current understanding of the intratumoral microbiome in various tumors","volume":"4","author":"Xue","year":"2023","journal-title":"Cell Rep Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006480","article-title":"The microbiome and the hallmarks of cancer","volume":"13","author":"Fulbright","year":"2017","journal-title":"PloS Pathog"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.08.004","article-title":"Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00908-9","article-title":"Exploiting bacteria for cancer immunotherapy","volume":"21","author":"Kwon","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114085","article-title":"Bacteria and bacterial derivatives as delivery carriers for immunotherapy","volume":"181","author":"Kang","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2934","article-title":"Engineering the perfect (bacterial) cancer therapy","volume":"10","author":"Forbes","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.09.007","article-title":"The impact of intratumoral and gastrointestinal microbiota on systemic cancer therapy","volume":"39","author":"Cogdill","year":"2018","journal-title":"Trends Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200470","article-title":"Microbiota in tumors: From understanding to application","volume":"9","author":"Xie","year":"2022","journal-title":"Adv Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: Roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2025.110907","article-title":"Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy","volume":"36","author":"Feng","year":"2025","journal-title":"Chin Chem Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2025.111093","article-title":"Engineered bacteria potentiate cancer immunotherapy","volume":"36","author":"Sun","year":"2025","journal-title":"Chin Chem Lett"},{"key":"B33","doi-asserted-by":"publisher","first-page":"112912","DOI":"10.1016\/j.cclet.2026.112912","article-title":"Immunomodulatory microbials for cancer immunotherapy: A mini review","author":"Hou","year":"2026","journal-title":"Chin Chem Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2026.175161","article-title":"Targeting the intratumoral microbiome with advanced nanoplatforms: Overcoming therapeutic resistance in cancer","volume":"534","author":"Li","year":"2026","journal-title":"Chem Eng J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1269054","article-title":"Intratumor microbiota in cancer pathogenesis and immunity: From mechanisms of action to therapeutic opportunities","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846632","article-title":"Bacterial infections and cancer","volume":"19","author":"van Elsland","year":"2018","journal-title":"EMBO Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2007.11.001","article-title":"Delivery of a salmonella typhi exotoxin from a host intracellular compartment","volume":"3","author":"Spano","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41423-019-0339-5","article-title":"Molecular anatomy and pathogenic actions of helicobacter pylori caga that underpin gastric carcinogenesis","volume":"17","author":"Takahashi-Kanemitsu","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax2685","article-title":"Structure elucidation of colibactin and its DNA cross-links","volume":"365","author":"Xue","year":"2019","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21315\/mjms2020.27.4.2","article-title":"The mechanism of bacteroides fragilis toxin contributes to colon cancer formation","volume":"27","author":"Cheng","year":"2020","journal-title":"Malays J Med Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41467-020-15549-6","article-title":"Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer","volume":"11","author":"Irrazabal","year":"2020","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010203108","article-title":"Polyamine catabolism contributes to enterotoxigenic bacteroides fragilis-induced colon tumorigenesis","volume":"108","author":"Goodwin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI125581","article-title":"H. Pylori infection alters repair of DNA double-strand breaks via snhg17","volume":"130","author":"Han","year":"2020","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01465-18","article-title":"Chlamydia trachomatis inhibits homologous recombination repair of DNA breaks by interfering with pp2a signaling","volume":"9","author":"Mi","year":"2018","journal-title":"mBio"},{"key":"B45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-020-00847-4","article-title":"Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer","volume":"8","author":"Xia","year":"2020","journal-title":"Microbiome"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1037406","article-title":"Microbiota composition and its impact on DNA methylation in colorectal cancer","volume":"14","author":"Gutierrez-Angulo","year":"2023","journal-title":"Front Genet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12964-015-0111-0","article-title":"Helicobacter pylori virulence factor caga promotes tumorigenesis of gastric cancer via multiple signaling pathways","volume":"13","author":"Yong","year":"2015","journal-title":"Cell Commun Signal"},{"key":"B48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating e-cadherin\/beta-catenin signaling via its fada adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03455","article-title":"Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent e-cadherin cleavage","volume":"120","author":"Wu","year":"2007","journal-title":"J Cell Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105011","article-title":"Salmonella enterica subsp. Enterica host-pathogen interactions and their implications in gallbladder cancer","volume":"157","author":"Khan","year":"2021","journal-title":"Microb Pathog"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01226-13","article-title":"Diverse toll-like receptors mediate cytokine production by fusobacterium nucleatum and aggregatibacter actinomycetemcomitans in macrophages","volume":"82","author":"Park","year":"2014","journal-title":"Infect Immun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.022","article-title":"The nod-like receptor nlrp12 attenuates colon inflammation and tumorigenesis","volume":"20","author":"Zaki","year":"2011","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1016814108","article-title":"Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and nlrc4","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100050","article-title":"The nlrp3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer","volume":"207","author":"Allen","year":"2010","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI62236","article-title":"Nod2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer","volume":"123","author":"Couturier-Maillard","year":"2013","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002046","article-title":"Il-18 production downstream of the nlrp3 inflammasome confers protection against colorectal tumor formation","volume":"185","author":"Zaki","year":"2010","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100412","article-title":"A functional role for nlrp6 in intestinal inflammation and tumorigenesis","volume":"186","author":"Chen","year":"2011","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.04.022","article-title":"Nlrp6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1307575110","article-title":"Microbiota-induced activation of epithelial il-6 signaling links inflammasome-driven inflammation with transmissible cancer","volume":"110","author":"Hu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive il-23\/il-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.03.039","article-title":"The multifaceted role of the intestinal microbiota in colon cancer","volume":"54","author":"Irrazabal","year":"2014","journal-title":"Mol Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3610","article-title":"The microbiome and cancer","volume":"13","author":"Schwabe","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:28:3:187","article-title":"Involvement of il-6 in the pathogenesis of inflammatory bowel disease and colon cancer","volume":"28","author":"Atreya","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"Stats in cancer inflammation and immunity: A leading role for stat3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal microbiota promote lung cancer development via gammadelta t cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.692544","article-title":"Fusobacterium nucleatum cbpf mediates inhibition of t cell function through ceacam1 activation","volume":"11","author":"Galaski","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/IAI.00674-17","article-title":"Salmonella enterica serovar typhimurium increases functional pd-l1 synergistically with gamma interferon in intestinal epithelial cells via salmonella pathogenicity island 2","volume":"86","author":"Sahler","year":"2018","journal-title":"Infect Immun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04217.x","article-title":"Increased programmed death-ligand-1 expression in human gastric epithelial cells in helicobacter pylori infection","volume":"161","author":"Wu","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00558-0","article-title":"The gut microbial metabolite formate exacerbates colorectal cancer progression","volume":"4","author":"Ternes","year":"2022","journal-title":"Nat Metab"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic short chain fatty acids limit antitumor effect of ctla-4 blockade in hosts with cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301679","article-title":"Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics","volume":"10","author":"Goto","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116041","article-title":"Tumor-isolated cutibacterium acnes as an effective tumor suppressive living drug","volume":"170","author":"Chintalapati","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2021.03.053","article-title":"Intratumour microbiome associated with the infiltration of cytotoxic cd8+ t cells and patient survival in cutaneous melanoma","volume":"151","author":"Zhu","year":"2021","journal-title":"Eur J Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.11.003","article-title":"Microbiota-specific t follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer","volume":"54","author":"Overacre-Delgoffe","year":"2021","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03368-8","article-title":"Identification of bacteria-derived hla-bound peptides in melanoma","volume":"592","author":"Kalaora","year":"2021","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135597","article-title":"Commensal bacteria stimulate antitumor responses via t cell cross-reactivity","volume":"5","author":"Bessell","year":"2020","journal-title":"JCI Insight"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0701","article-title":"Cross-reactivity between tumor mhc class i-restricted antigens and an enterococcal bacteriophage","volume":"369","author":"Fluckiger","year":"2020","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12967-022-03512-6","article-title":"Molecular mimicry between tumor associated antigens and microbiota-derived epitopes","volume":"20","author":"Ragone","year":"2022","journal-title":"J Transl Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-023-01776-0","article-title":"Molecular mimicry and cancer vaccine development","volume":"22","author":"Tagliamonte","year":"2023","journal-title":"Mol Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303006","article-title":"Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large european prospective cohort study","volume":"62","author":"Michaud","year":"2013","journal-title":"Gut"},{"key":"B84","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12866-021-02339-3","article-title":"Role of biliary stent and neoadjuvant chemotherapy in the pancreatic tumor microbiome","volume":"21","author":"Nalluri","year":"2021","journal-title":"BMC Microbiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25276","article-title":"Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: Results from a prospective, multicenter nodal ultrastaging trial","volume":"9","author":"Noguti","year":"2018","journal-title":"Oncotarget"},{"key":"B87","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1038\/s41598-021-86816-9","article-title":"Prognostic value of intratumoral fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients","volume":"11","author":"Neuzillet","year":"2021","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.785422","article-title":"Intratumor microbiome analysis identifies positive association between megasphaera and survival of chinese patients with pancreatic ductal adenocarcinomas","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113856","article-title":"Bacteriophage-mediated modulation of microbiota for diseases treatment","volume":"176","author":"Zhang","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.05.006","article-title":"Targeted depletion of bacteria from mixed populations by programmable adhesion with antagonistic competitor cells","volume":"28","author":"Ting","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2020.11.003","article-title":"Enhancing phage therapy through synthetic biology and genome engineering","volume":"68","author":"Lenneman","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003572","article-title":"Bacteria-based cancer immunotherapy","volume":"8","author":"Huang","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11307-007-0120-5","article-title":"Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting escherichia coli","volume":"10","author":"Min","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.4068\/cmj.2016.52.3.173","article-title":"Targeted cancer therapy using engineered salmonella typhimurium","volume":"52","author":"Zheng","year":"2016","journal-title":"Chonnam Med J"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1006\/anae.1998.0161","article-title":"Colonisation of clostridium in the body is restricted to hypoxic and necrotic areas of tumours","volume":"4","author":"Lambin","year":"1998","journal-title":"Anaerobe"},{"key":"B97","doi-asserted-by":"publisher","first-page":"249ra111","DOI":"10.1126\/scitranslmed.3008982","article-title":"Intratumoral injection of clostridium novyi-nt spores induces antitumor responses","volume":"6","author":"Roberts","year":"2014","journal-title":"Sci Transl Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40425-018-0381-3","article-title":"White paper on microbial anti-cancer therapy and prevention","volume":"6","author":"Forbes","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/nq\/s1-i.14.215d","article-title":"Sparse initial entrapment of systemically injected salmonella typhimurium leads to heterogeneous accumulation within tumors","volume":"63","author":"Forbes","year":"2003","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/bit.20883","article-title":"Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro","volume":"94","author":"Kasinskas","year":"2006","journal-title":"Biotechnol Bioeng"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408422102","article-title":"Tumor-targeting bacterial therapy with amino acid auxotrophs of gfp-expressing salmonella typhimurium","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006692","article-title":"Tumor invasion of salmonella enterica serovar typhimurium is accompanied by strong hemorrhage promoted by tnf-alpha","volume":"4","author":"Leschner","year":"2009","journal-title":"PloS One"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2618","article-title":"Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis","volume":"67","author":"Kasinskas","year":"2007","journal-title":"Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00993.x","article-title":"Cell biology and immunology of listeria monocytogenes infections: Novel insights","volume":"240","author":"Stavru","year":"2011","journal-title":"Immunol Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.206","article-title":"Myeloid-derived suppressor cells have a central role in attenuated listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice","volume":"108","author":"Chandra","year":"2013","journal-title":"Br J Cancer"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2012.59","article-title":"Bacterial vectors for imaging and cancer gene therapy: A review","volume":"19","author":"Cronin","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.251543698","article-title":"Combination bacteriolytic therapy for the treatment of experimental tumors","volume":"98","author":"Dang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.12.014","article-title":"Trg-deficient salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating","volume":"199","author":"Zhang","year":"2015","journal-title":"J Control Release"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700777","article-title":"Systemic administration of attenuated salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model","volume":"12","author":"Lee","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2984","article-title":"Containment of tumor-colonizing bacteria by host neutrophils","volume":"68","author":"Westphal","year":"2008","journal-title":"Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2010.02.004","article-title":"Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility","volume":"300","author":"Stritzker","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0406242101","article-title":"Bacteriolytic therapy can generate a potent immune response against experimental tumors","volume":"101","author":"Agrawal","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2987","article-title":"Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens","volume":"15","author":"Branzk","year":"2014","journal-title":"Nat Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2011.10","article-title":"In tumors salmonella migrate away from vasculature toward the transition zone and induce apoptosis","volume":"18","author":"Ganai","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2013.86","article-title":"Salmonella induce autophagy in melanoma by the downregulation of akt\/mtor pathway","volume":"21","author":"Lee","year":"2014","journal-title":"Gene Ther"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1993","article-title":"Activation of toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth","volume":"71","author":"Cai","year":"2011","journal-title":"Cancer Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-08-4855","article-title":"High efficacy of a listeria-based vaccine against metastatic breast cancer rreveals a dual mode of action","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3515-4_14","article-title":"Salmonella typhimurium a1-r and cell-cycle decoy therapy of cancer","volume":"1409","author":"Hoffman","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4161\/15384101.2014.964115","article-title":"Tumor-targeting salmonella typhimurium a1-r decoys quiescent cancer cells to cycle as visualized by fucci imaging and become sensitive to chemotherapy","volume":"13","author":"Yano","year":"2014","journal-title":"Cell Cycle"},{"key":"B120","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1128\/mr.48.3.199-221.1984","article-title":"Bacterial toxins: Cellular mechanisms of action","volume":"48","author":"Middlebrook","year":"1984","journal-title":"Microbiol Rev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.4161\/hv.23871","article-title":"Listeriolysin o as a strong immunogenic molecule for the development of new anti-tumor vaccines","volume":"9","author":"Sun","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605403","article-title":"Tumour-targeted delivery of trail using salmonella typhimurium enhances breast cancer survival in mice","volume":"101","author":"Ganai","year":"2009","journal-title":"Br J Cancer"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301499","article-title":"Radio-responsive reca promoter significantly increases tnfalpha production in recombinant clostridia after 2 gy irradiation","volume":"8","author":"Nuyts","year":"2001","journal-title":"Gene Ther"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn205","article-title":"Inhibition of tumor growth using salmonella expressing fas ligand","volume":"100","author":"Loeffler","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2015.7","article-title":"L-asparaginase delivered by salmonella typhimurium suppresses solid tumors","volume":"2","author":"Kim","year":"2015","journal-title":"Mol Ther Oncolytics"},{"key":"B126","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13036-019-0189-9","article-title":"Intestinal probiotics e. Coli nissle 1917 as a targeted vehicle for delivery of p53 and tum-5 to solid tumors for cancer therapy","volume":"13","author":"He","year":"2019","journal-title":"J Biol Eng"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20486","article-title":"Escherichia coli nissle 1917 engineered to express tum-5 can restrain murine melanoma growth","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700634","article-title":"Pilot trial of genetically modified, attenuated salmonella expressing the e. Coli cytosine deaminase gene in refractory cancer patients","volume":"10","author":"Nemunaitis","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-28-155","article-title":"A novel bifidobacterium infantis-mediated tk\/gcv suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer","volume":"28","author":"Tang","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/cgt.2008.10","article-title":"Tumor-targeting prodrug-activating bacteria for cancer therapy","volume":"15","author":"Cheng","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-07-4800","article-title":"Attenuated salmonella targets prodrug activating enzyme carboxypeptidase g2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy","volume":"14","author":"Friedlos","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/s0958-1669(00)00247-0","article-title":"Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers","volume":"12","author":"Weiss","year":"2001","journal-title":"Curr Opin Biotechnol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.626","article-title":"Endostatin gene therapy delivered by salmonella choleraesuis in murine tumor models","volume":"6","author":"Lee","year":"2004","journal-title":"J Gene Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jgm.1191","article-title":"Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated salmonella enterica serovar typhimurium in murine tumor models","volume":"10","author":"Fu","year":"2008","journal-title":"J Gene Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-07-0098","article-title":"Intratumoral delivery and suppression of prostate tumor growth by attenuated salmonella enterica serovar typhimurium carrying plasmid-based small interfering rnas","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.7.1.5195","article-title":"Oral administration of attenuated s. Typhimurium carrying shrna-expressing vectors as a cancer therapeutic","volume":"7","author":"Yang","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"B137","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.08.021","article-title":"Potent anti-tumor activity of systemically-administered il2-expressing salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis","volume":"130","author":"al-Ramadi","year":"2009","journal-title":"Clin Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0701959104","article-title":"Attenuated salmonella engineered to produce human cytokine light inhibit tumor growth","volume":"104","author":"Loeffler","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9537","article-title":"Two-step enhanced cancer immunotherapy with engineered salmonella typhimurium secreting heterologous flagellin","volume":"9","author":"Zheng","year":"2017","journal-title":"Sci Transl Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/sj.cgt.7701109","article-title":"Cancer immunotherapy based on recombinant salmonella enterica serovar typhimurium aroa strains secreting prostate-specific antigen and cholera toxin subunit b","volume":"15","author":"Fensterle","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28045","article-title":"In vivo antigen delivery by a salmonella typhimurium type iii secretion system for therapeutic cancer vaccines","volume":"116","author":"Nishikawa","year":"2006","journal-title":"J Clin Invest"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-019-0089-7","article-title":"Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (ido) activates innate immunity and mitigates colorectal cancer growth","volume":"27","author":"Phan","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0193","article-title":"Systemic delivery of salmonella typhimurium transformed with ido shrna enhances intratumoral vector colonization and suppresses tumor growth","volume":"72","author":"Blache","year":"2012","journal-title":"Cancer Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8120617","article-title":"Salmonella-based therapy targeting indoleamine 2,3-dioxygenase restructures the immune contexture to improve checkpoint blockade efficacy","volume":"8","author":"Ebelt","year":"2020","journal-title":"Biomedicines"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29432","article-title":"Combination of attenuated salmonella carrying pd-1 sirna with nifuroxazide for colon cancer therapy","volume":"121","author":"Zhao","year":"2020","journal-title":"J Cell Biochem"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae115","article-title":"Metastatic extraneural glioblastoma diagnosed with molecular testing","volume":"29","author":"Majd","year":"2024","journal-title":"Oncologist"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.017","article-title":"A novel salmonella typhi-based immunotherapy promotes tumor killing via an antitumor th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer","volume":"29","author":"Vendrell","year":"2011","journal-title":"Vaccine"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.09.006","article-title":"Bacteria-based immune therapies for cancer treatment","volume":"86","author":"Howell","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.10.033","article-title":"Targeted cancer immunotherapy with genetically engineered oncolytic salmonella typhimurium","volume":"469","author":"Guo","year":"2020","journal-title":"Cancer Lett"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.7150\/thno.11432","article-title":"Salmonella typhimurium suppresses tumor growth via the pro-inflammatory cytokine interleukin-1beta","volume":"5","author":"Kim","year":"2015","journal-title":"Theranostics"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1111\/1348-0421.12333","article-title":"Activation of inflammasome by attenuated salmonella typhimurium in bacteria-mediated cancer therapy","volume":"59","author":"Phan","year":"2015","journal-title":"Microbiol Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/s41467-021-22755-3","article-title":"Ifn-\u03b3-dependent nk cell activation is essential to metastasis suppression by engineered salmonella","volume":"12","author":"Lin","year":"2021","journal-title":"Nat Commun"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097418","article-title":"In vivo ifn-\u03b3 secretion by nk cells in response to salmonella typhimurium requires nlrc4 inflammasomes","volume":"9","author":"Kupz","year":"2014","journal-title":"PloS One"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2008.48","article-title":"Il-18-producing salmonella inhibit tumor growth","volume":"15","author":"Loeffler","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2012.28","article-title":"Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents","volume":"20","author":"Jarosz","year":"2013","journal-title":"Gene Ther"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41467-020-16602-0","article-title":"Immunotherapy with engineered bacteria by targeting the sting pathway for anti-tumor immunity","volume":"11","author":"Leventhal","year":"2020","journal-title":"Nat Commun"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.02.002","article-title":"Bacterial immunotherapy leveraging il-10r hysteresis for both phagocytosis evasion and tumor immunity revitalization","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.08.023","article-title":"Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic salmonella typhimurium","volume":"30","author":"Tan","year":"2022","journal-title":"Mol Ther"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1801910115","article-title":"Recombinant listeria promotes tumor rejection by cd8+ t cell-dependent remodeling of the tumor microenvironment","volume":"115","author":"Deng","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.1996.11.145","article-title":"Attenuated salmonella typhimurium containing interleukin-2 decreases mc-38 hepatic metastases: A novel anti-tumor agent","volume":"11","author":"Saltzman","year":"1996","journal-title":"Cancer Biother Radiopharm"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122135","article-title":"Synergistic cancer immunotherapy utilizing programmed salmonella typhimurium secreting heterologous flagellin b conjugated to interleukin-15 proteins","volume":"298","author":"Zhang","year":"2023","journal-title":"Biomaterials"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0555-9","article-title":"Salmonella typhimurium engineered to produce ccl21 inhibit tumor growth","volume":"58","author":"Loeffler","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci Transl Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2013.64","article-title":"Attenuated listeria monocytogenes as a cancer vaccine vector for the delivery of cd24, a biomarker for hepatic cancer stem cells","volume":"11","author":"Yang","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01722.x","article-title":"Tumor antigen delivered by salmonella iii secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma","volume":"101","author":"Zhu","year":"2010","journal-title":"Cancer Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00044-10","article-title":"Oral vaccination with attenuated salmonella enterica strains encoding t-cell epitopes from tumor antigen ny-eso-1 induces specific cytotoxic t-lymphocyte responses","volume":"17","author":"Meng","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034214","article-title":"Cd8 t-cell induction against vascular endothelial growth factor receptor 2 by salmonella for vaccination purposes against a murine melanoma","volume":"7","author":"Jellbauer","year":"2012","journal-title":"PloS One"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1456603","article-title":"Heterologous vaccination targeting prostatic acid phosphatase (pap) using DNA and listeria vaccines elicits superior anti-tumor immunity dependent on cd4+ t cells elicited by DNA priming","volume":"7","author":"Johnson","year":"2018","journal-title":"Oncoimmunology"},{"key":"B170","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1245\/s10434-011-2037-0","article-title":"Tumor-associated antigen expressing listeria monocytogenes induces effective primary and memory t-cell responses against hepatic colorectal cancer metastases","volume":"19","author":"Olino","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i12.1833","article-title":"Oral attenuated salmonella typhimurium vaccine against mg7-ag mimotope of gastric cancer","volume":"11","author":"Meng","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self\/tumor-reactive cd8+ t cells confer superior antitumor immunity compared with effector memory t cells","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3160","article-title":"Intracellular bacterial vectors that induce cd8+ t cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection","volume":"69","author":"Stark","year":"2009","journal-title":"Cancer Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijmm.2007.07.002","article-title":"Salmonella type iii-mediated heterologous antigen delivery: A versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors","volume":"298","author":"Panthel","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00072","article-title":"An oral salmonella-based vaccine inhibits liver metastases by promoting tumor-specific t-cell-mediated immunity in celiac and portal lymph nodes: A preclinical study","volume":"7","author":"Vendrell","year":"2016","journal-title":"Front Immunol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.4.613","article-title":"Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells","volume":"191","author":"Yrlid","year":"2000","journal-title":"J Exp Med"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00438","article-title":"Immature, semi-mature, and fully mature dendritic cells: Toward a dc-cancer cells interface that augments anticancer immunity","volume":"4","author":"Dudek","year":"2013","journal-title":"Front Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"44ra57","DOI":"10.1126\/scitranslmed.3000739","article-title":"Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity","volume":"2","author":"Saccheri","year":"2010","journal-title":"Sci Transl Med"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000000","article-title":"Listeria monocytogenes (lm)-llo immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory t cells in the tumor microenvironment","volume":"36","author":"Wallecha","year":"2013","journal-title":"J Immunother"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28926","article-title":"Attenuated listeria monocytogenes reprograms m2-polarized tumor-associated macrophages in ovarian cancer leading to inos-mediated tumor cell lysis","volume":"3","author":"Lizotte","year":"2014","journal-title":"Oncoimmunology"},{"key":"B181","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41419-019-1418-3","article-title":"Pd-1-sirna delivered by attenuated salmonella enhances the antimelanoma effect of pimozide","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112840","article-title":"Arginase: An emerging and promising therapeutic target for cancer treatment","volume":"149","author":"Niu","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates t-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"B185","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/jco.2002.20.1.142","article-title":"Phase i study of the intravenous administration of attenuated salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J Clin Oncol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/1078-0432.Ccr-20-2065","article-title":"Intratumoral injection of clostridium novyi-nt spores in patients with treatment-refractory advanced solid tumors","volume":"27","author":"Janku","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1097\/igc.0000000000001235","article-title":"A randomized phase 2 study of adxs11-001 listeria monocytogenes-listeriolysin o immunotherapy with or without cisplatin in treatment of advanced cervical cancer","volume":"28","author":"Basu","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-23-0118","article-title":"Phase i study of synb1891, an engineered e. Coli nissle strain expressing sting agonist, with and without atezolizumab in advanced Malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S438164","article-title":"Bacteria-based nanoprobes for cancer therapy","volume":"19","author":"Lu","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: Bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp Mol Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.01.037","article-title":"Genetically engineered salmonella typhimurium: Recent advances in cancer therapy","volume":"448","author":"Liang","year":"2019","journal-title":"Cancer Lett"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.172","article-title":"Engineering bacteria for diagnostic and therapeutic applications","volume":"16","author":"Riglar","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/0008-5472.CAN-09-3453","article-title":"Genetically engineered salmonella typhimurium as an imageable therapeutic probe for cancer","volume":"70","author":"Nguyen","year":"2010","journal-title":"Cancer Res"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1021\/bp010141k","article-title":"Effect of lacy expression on homogeneity of induction from the ptac and ptrc promoters by natural and synthetic inducers","volume":"18","author":"Khlebnikov","year":"2002","journal-title":"Bio\/Technol Prog"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1101\/gad.892001","article-title":"The lac operator-repressor system is functional in the mouse","volume":"15","author":"Cronin","year":"2001","journal-title":"Genes Dev"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth1107","article-title":"In vivo gene regulation in salmonella spp. By a salicylate-dependent control circuit","volume":"4","author":"Royo","year":"2007","journal-title":"Nat Methods"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-023-01879-6","article-title":"Reprogramming a doxycycline-inducible gene switch system for bacteria-mediated cancer therapy","volume":"26","author":"Ngo","year":"2024","journal-title":"Mol Imaging Biol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11307-021-01624-x","article-title":"Optimized doxycycline-inducible gene expression system for genetic programming of tumor-targeting bacteria","volume":"24","author":"Nguyen","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-020-02851-y","article-title":"Design and evaluation of biological gate circuits and their therapeutic applications in a model of multidrug resistant cancers","volume":"42","author":"Soheili","year":"2020","journal-title":"Biotechnol Lett"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c14633","article-title":"Upconversion optogenetic engineered bacteria system for time-resolved imaging diagnosis and light-controlled cancer therapy","volume":"14","author":"Zhang","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1029403","article-title":"Light-regulated gene expression in bacteria: Fundamentals, advances, and perspectives","volume":"10","author":"Ohlendorf","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.188","article-title":"Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors","volume":"16","author":"Ryan","year":"2009","journal-title":"Gene Ther"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105086","article-title":"Bacteria-elicited specific thrombosis utilizing acid-induced cytolysin a expression to enable potent tumor therapy","volume":"9","author":"Qin","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3390\/bios13020266","article-title":"Genetic programming by nitric oxide-sensing gene switch system in tumor-targeting bacteria","volume":"13","author":"Qin","year":"2023","journal-title":"Biosens-Basel"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0186-5","article-title":"Bacterial quorum sensing in complex and dynamically changing environments","volume":"17","author":"Mukherjee","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414558112","article-title":"Quorum-sensing salmonella selectively trigger protein expression within tumors","volume":"112","author":"Swofford","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00285-3","article-title":"Engineering living therapeutics with synthetic biology","volume":"20","author":"Cubillos-Ruiz","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1126\/science.1206843","article-title":"Synthetic biology moving into the clinic","volume":"333","author":"Ruder","year":"2011","journal-title":"Science"},{"key":"B211","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41551-018-0215-0","article-title":"Synthetic gene circuits for the detection, elimination and prevention of disease","volume":"2","author":"Sedlmayer","year":"2018","journal-title":"Nat BioMed Eng"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41467-022-29065-2","article-title":"Ultrasound-controllable engineered bacteria for cancer immunotherapy","volume":"13","author":"Abedi","year":"2022","journal-title":"Nat Commun"},{"key":"B213","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.1232758","article-title":"Amplifying genetic logic gates","volume":"340","author":"Bonnet","year":"2013","journal-title":"Science"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1038\/srep00436","article-title":"Explicit hypoxia targeting with tumor suppression by creating an \"obligate\" anaerobic salmonella typhimurium strain","volume":"2","author":"Yu","year":"2012","journal-title":"Sci Rep"},{"key":"B215","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41551-021-00772-3","article-title":"Enhancing the tropism of bacteria via genetically programmed biosensors","volume":"6","author":"Chien","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1002\/bit.10892","article-title":"Functional display of foreign protein on surface of escherichia coli using n-terminal domain of ice nucleation protein","volume":"85","author":"Li","year":"2004","journal-title":"Biotechnol Bioeng"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.4524","article-title":"Molecular characterization of an ice nucleation protein variant (inaq) from pseudomonas syringae and the analysis of its transmembrane transport activity in escherichia coli","volume":"8","author":"Li","year":"2012","journal-title":"Int J Biol Sci"},{"key":"B219","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","article-title":"Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention","volume":"2","author":"Ho","year":"2018","journal-title":"Nat BioMed Eng"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.7150\/thno.16135","article-title":"Rgd peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated salmonella-mediated cancer therapy","volume":"6","author":"Park","year":"2016","journal-title":"Theranostics"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.008","article-title":"Improving tumor targeting and therapeutic potential of salmonella vnp20009 by displaying cell surface cea-specific antibodies","volume":"25","author":"Bereta","year":"2007","journal-title":"Vaccine"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-474098","article-title":"Salmonella engineered to express cd20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas","volume":"122","author":"Massa","year":"2013","journal-title":"Blood"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S237544","article-title":"Aptamers as versatile ligands for biomedical and pharmaceutical applications","volume":"15","author":"Guan","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"B224","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1038\/s41467-021-26956-8","article-title":"Aptamer-assisted tumor localization of bacteria for enhanced biotherapy","volume":"12","author":"Geng","year":"2021","journal-title":"Nat Commun"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S329855","article-title":"Nanotechnology-employed bacteria-based delivery strategy for enhanced anticancer therapy","volume":"16","author":"Ye","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1021\/nn5011304","article-title":"Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents","volume":"8","author":"Taherkhani","year":"2014","journal-title":"ACS Nano"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.7b05323","article-title":"Bacteria-mediated tumor therapy utilizing photothermally-controlled tnf-\u03b1 expression via oral administration","volume":"18","author":"Fan","year":"2018","journal-title":"Nano Lett"},{"key":"B228","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbrc.2022.03.049","article-title":"Drug-loaded nanoparticles conjugated with genetically engineered bacteria for cancer therapy","volume":"606","author":"Du","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.5b00570","article-title":"Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy","volume":"15","author":"Hu","year":"2015","journal-title":"Nano Lett"},{"key":"B230","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","article-title":"Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria","volume":"6","author":"Wang","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B231","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2016.09.007","article-title":"Bioengineered and biohybrid bacteria-based systems for drug delivery","volume":"106","author":"Hosseinidoust","year":"2016","journal-title":"Adv Drug Delivery Rev"},{"key":"B232","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.1038\/s41598-018-28102-9","article-title":"Motility and chemotaxis of bacteria-driven microswimmers fabricated using antigen 43-mediated biotin display","volume":"8","author":"Schauer","year":"2018","journal-title":"Sci Rep"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b03207","article-title":"Multifunctional bacteria-driven microswimmers for targeted active drug delivery","volume":"11","author":"Park","year":"2017","journal-title":"ACS Nano"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1126\/scirobotics.aar4423","article-title":"Soft erythrocyte-based bacterial microswimmers for cargo delivery","volume":"3","author":"Alapan","year":"2018","journal-title":"Sci Robot"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo6163","article-title":"Magnetically steerable bacterial microrobots moving in 3d biological matrices for stimuli-responsive cargo delivery","volume":"8","author":"Akolpoglu","year":"2022","journal-title":"Sci Adv"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1126\/scirobotics.abo0665","article-title":"Magnetic torque-driven living microrobots for increased tumor infiltration","volume":"7","author":"Gwisai","year":"2022","journal-title":"Sci Robot"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201906766","article-title":"Pros and cons: Magnetic versus optical microrobots","volume":"32","author":"Sitti","year":"2020","journal-title":"Adv Mater"},{"key":"B238","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1038\/s41467-023-37225-1","article-title":"Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0437-6","article-title":"Live biotherapeutic products: The importance of a defined regulatory framework","volume":"52","author":"Cordaillat-Simmons","year":"2020","journal-title":"Exp Mol Med"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-023-00078-w","article-title":"From science to business: Translating live biotherapeutic products to the clinic","volume":"1","author":"Lluch-Senar","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.5617","article-title":"Incidence of placebo adverse events in randomized clinical trials of targeted and immunotherapy cancer drugs in the adjuvant setting: A systematic review and meta-analysis","volume":"1","author":"Chacon","year":"2018","journal-title":"JAMA Netw Open"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi316","article-title":"Pharmacologic and toxicologic evaluation of c. Novyi-nt spores","volume":"88","author":"Diaz","year":"2005","journal-title":"Toxicol Sci"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3627","article-title":"Clostridium novyi-nt can cause regression of orthotopically implanted glioblastomas in rats","volume":"6","author":"Staedtke","year":"2015","journal-title":"Oncotarget"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1002\/bit.21785","article-title":"Establishment and characterization of conditions required for tumor colonization by intravenously delivered bacteria","volume":"100","author":"Yu","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061674","article-title":"Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: Protocol for a multicentre, prospective, observational study","volume":"12","author":"Shoji","year":"2022","journal-title":"BMJ Open"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2022.116825","article-title":"Artificial intelligence-based decision support model for new drug development planning","volume":"198","author":"Jung","year":"2022","journal-title":"Expert Syst Appl"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110255","article-title":"The emerging roles of artificial intelligence in cancer drug development and precision therapy","volume":"128","author":"Liang","year":"2020","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1878878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:59:48Z","timestamp":1785239988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1878878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":247,"alternative-id":["10.3389\/fimmu.2026.1878878"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1878878","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1878878"}}